Wednesday, August 10, 2005

Vai sonhando

Em vez da tradicional avalanche de disparates, opto neste post por confrontar dois pontos de vista em relação a "Os Sonhadores" de Bertolucci.

O de alguém bem mais entendido sobre a obra de Bertolluci, mas céptico relativamente às maravilhas da Criterion Collection:

Os Sonhadores será sempre um filme-fetiche, realizado por um homem que é para mim o cineasta (mal compreendido) da luxúria, Bernardo Bertolucci. Não esqueço a admirável recuperação do Acossado do Godard, no pregão "New York Herald Tribune". Ou, ainda Godard, a tentativa de bater a façanha do Louvre de Bande à Part. Ou mesmo o despique verbal entre Chaplin e Keaton, ou entre Clapton e Hendrix - fico-me sempre pelos segundos. Os diálogos contrastam, às vezes, com a cenografia "gratuita", é verdade. Mas são perturbantes as navalhadas no Maio de 68 e na guerra do Vietname, ou como uma declaração anti-guerra é um poema. Sobretudo porque acredito que muita gente viveu assim esses episódios históricos.

É um filme improvável. Veja-se as cenas da tentativa de suicídio ( Rosetta, dos irmãos belgas Dardenne, é contemporâneo deste filme e isso percebe-se bem nesta passagem) e da rua a entrar-lhes pela janela - já que eles se estavam nas tintas para a revolução. É quase impossível este filme, de tão narcísico (como disseste (em debate verbal havido anteriormente)), como era quase impossível O Último Tango em Paris . Mas Bertolucci filmou ambos. É cinema que se olha até à náusea, na ânsia da auto-referencialidade a roçar o pueril. Mas um cinema apaixonante e apaixonado, nem que seja por si. Os Sonhadores é assim. Não é assim também Tarnation , de Jonathan Caouette? Mas concedo, por fim, que, por ter tanta sacarose, acaba por fazer mal aos dentes. É que Bertolucci nunca estudou até ao fim a lição dos grandes, não deixando por isso de ser um deles.

A minha resposta:

Posso adiantar que eu concordo com quase tudo o que referes. Eu não conheço assim tão bem o Bertolucci p admirar essa auto-referencialidade. Mas se for por aí todas as sagas são grandes filmes. Aquelas colagens e referências à nova vaga e a outros tantos clássicos são pura sedução de cinéfilos. Ou estás dentro ou estás fora. Tu estás dentro, eu estou fora. Eu disse que "pode até" ser narcísista e não malhei nisso. O filme tem um início e fim extremamente deficientes. Em 15 minutos o trio une-se. Em 5 minutos o trio desfaz-se. Já o "Tango" também jogava com a intimidade súbita, pelo que sei e pouco me lembro. Este não me papa talvez porque é gráfico quando nem sequer precisa de o ser. Parece-me ser um filme que acena com demasiadas bandeiras e depois não tem muito para dar.

Além disso, o trio de actores revela-se aquém das suas capacidades. Michael Pitt mais parece um Leonardo Di Caprio dos anos pré-Titanic.(spoilers ahead) E alguém acredita que a protagonista era virgem?

1 Comments:

At 6:29 AM, Blogger mandyprehiem0869 said...

St0ck For Your Review - FCPG

Current Profile
Faceprint Global Solutions (FCPG)
Current Price $0.15

A U.S. based-company dedicated to the goal of
bringing effective security solutions to the marketplace.

With violent and white-collar terrorism on the rise,
companies are starving for innovative security solutions.


FCPG is set to bring hot new security solutions to
the industry, with currently over 40 governmental and
non-governmental contracts, being negotiated.


Please Review Exactly What this Company Does.

Why consider Faceprint Global Solutions (FCPG)?

Faceprint Global Solutions (FCPG) holds the exclusive
marketing rights from Keyvelop, to sell the world�s
leading encryption technology to be distributed directly
to the Healthcare industry in North America.

Faceprint Global Solutions has completed its biometric
software that recognizes facial features of individuals
entering and leaving through airports, ship yards, banks,
large buildings, etc.

FCPG acquired Montreal-based Apometrix Technologies,
which enhances the companies mission of being a
full-service provider to the multi-application smart
card industry. The North American market appears ready
for significant expansion of price-competitive, proven,
multi-application solutions on smart cards. Apometrix's
forecast of over 300 customers and sales of more than $50
million in North America over the next five years, appears
very realistic, according to company management.


Faceprint Global Solutions is currently in contract negotiations
with over 40 governmental agencies and businesses seeking to use
their encryption, biometric, and smart-card technologies.

Breaking News for Faceprint Global Solutions (FCPG)

Faceprint Global Solutions (FCPG) is pleased to announce that
IBM will now offer the world�s leading encryption software to
its major Healthcare clients in North America.


With FCPG owning the exclusive North American rights to distribute
the worlds leading encryption and transmission software developed by
Keyvelop, FCPG is poised to capture large volumes of sales generated
by customers currently using IBM�s software in the healthcare and other
industries.


�This is a very positive move for FCPG and for Keyvelop,� said FCPG
CEO Pierre Cote. �We are very happy about the decision to go with IBM.
This is a continuation of the progress made by everyone associated
with FCPG and its partners.�

Buell Duncan, IBM's general manager of ISV & Developer Relations commented,
�Collaborating with Keyvelop will ensure that we develop open solutions that
are easy to maintain and cost effective for our customers in the healthcare
and life sciences industry.�

Among other things, this new software technology which is currently
being used by a number of European healthcare companies, is used to
send any file, regardless of format or size. Encryption keys, evidence
of transmission integrity with fingerprint calculation, time-stamping
of all actions and status record updating, pre-checking sender and
receiver identities, validating file opening dates are part of Keyvelop features.

About FacePrint Global Solutions, Inc.

FCPG operates a business, which develops and delivers a variety of
technology solutions, including biometric software applications on
smart cards and other support mediums (apometric solutions). FCPG�s
products provide biometric solutions for identity authentication and a
host of smart card- and biometrics-related hardware peripherals and
software applications. Apometrix, FCPG�s wholly-owned subsidiary,
combines on-card or in-chip multi-application management solutions
with best-of-breed �in-card matching� biometrics. Keyvelop�s secure
digital envelope solution and Apometrix�s on-card biometrics work
together to produce the winning combination in the fields of security,
traceability and identity management.

Conclusion:

The examples above show the Awesome, Earning Potential of little known
Companies That Explode onto Investor�s Radar Screens. This sto,ck will
not be a Secret for long. Then You May Feel the Desire to Act Right Now!
And Please Watch This One Trade!

GO FCPG!

Disclaimer:
Information within this email contains "forward |ooking statements" within
the meaning of Section 27Aof the Securities Act of 1933 and Section 21B of
the Securities Exchange Act of 1934. Any statements that express or involve
discussions with respect to predictions, expectations, beliefs, plans,
projections, objectives, goals, assumptions or future events or performance
are not statements of historical fact and may be "forward |ooking statements".
"Forward |ooking statements" are based on expectations, estimates and projections
at the time the statements are made that involve a number of risks and uncertainties
which could cause actual results or events to differ materially from those presently
anticipated. We were paid a sum of three thousand USD to disseminate this information
from ir marketing. Forward loking statements in this action may be identified through
the use of words such as "projects", "foresee", "expects", "will", "anticipates",
"estimates", "believes", "understands" or that by statements indicating
certain actions "may", "could", or "might" occur. Risk factors include
general economic and business conditions, the ability to acquire and develop
specific projects, the ability to fund operations and changes in consumer and
business consumption habits and other factors over which the company has little
or no control. The publisher of this newsletter does not represent that the
information contained herein are true and correct.

 

Post a Comment

<< Home